Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2010

Open Access 01-12-2010 | Case report

Anaphylactic response to topical fluorescein 2% eye drops: a case report

Authors: Humma Shahid, John F Salmon

Published in: Journal of Medical Case Reports | Issue 1/2010

Login to get access

Abstract

Introduction

The intravenous use of fluorescein 10% during retinal angiography can cause severe systemic reactions including, on rare occasions, anaphylaxis. Fluorescein 2% eye drops are used extensively for clinical examination and diagnosis, but to the best of our knowledge, they have only been reported as being responsible for a systemic anaphylactic response on two previous occasions.

Case presentation

We report the case of a 51-year-old woman who developed an anaphylactic reaction when she was administered fluorescein sodium 2% eye drops after cataract surgery. This was the second time she had been exposed to fluorescein. She had brittle asthma and a history of anaphylaxis following exposure to a variety of drug and food allergens. She was successfully resuscitated and recovered completely over a period of two days.

Conclusions

Fluorescein 2% drops are universally used in general practice, ophthalmology, optometry, and casualty departments. Our case report reveals the potential for this benign eye drop to cause a life-threatening systemic reaction and emphasises the importance of considering this consequence when administering topical fluorescein 2% to a patient with a history of anaphylaxis to other allergens.
Literature
1.
go back to reference Kwiterovich KA, Maguire MG, Murphy RP, Schachat AP, Bressler NM, Bressler SB, Fine SL: Frequency of adverse systemic reactions after fluorescein angiography: results of a prospective study. Ophthalmol. 1991, 98: 1139-1142.CrossRef Kwiterovich KA, Maguire MG, Murphy RP, Schachat AP, Bressler NM, Bressler SB, Fine SL: Frequency of adverse systemic reactions after fluorescein angiography: results of a prospective study. Ophthalmol. 1991, 98: 1139-1142.CrossRef
2.
go back to reference Yannuzzi LA, Rohrer KT, Tindel LJ, Sobel RS, Costanza MA, Shields W, Zang E: Fluorescein angiography complication survey. Ophthalmol. 1986, 93: 611-617.CrossRef Yannuzzi LA, Rohrer KT, Tindel LJ, Sobel RS, Costanza MA, Shields W, Zang E: Fluorescein angiography complication survey. Ophthalmol. 1986, 93: 611-617.CrossRef
3.
go back to reference Kwan AS, Barry C, McAllister IL, Constable I: Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience. Clin Exp Ophthalmol. 2006, 34: 33-38. 10.1111/j.1442-9071.2006.01136.x.CrossRef Kwan AS, Barry C, McAllister IL, Constable I: Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience. Clin Exp Ophthalmol. 2006, 34: 33-38. 10.1111/j.1442-9071.2006.01136.x.CrossRef
4.
go back to reference Baudouin C: Allergic reaction to topical eyedrops. Curr Opinion Allergy Clin Immunol. 2005, 5: 459-463. 10.1097/01.all.0000183112.86181.9e.CrossRef Baudouin C: Allergic reaction to topical eyedrops. Curr Opinion Allergy Clin Immunol. 2005, 5: 459-463. 10.1097/01.all.0000183112.86181.9e.CrossRef
5.
go back to reference El Harrar: Anaphylactic shock caused by application of fluorescein on the ocular conjunctiva. Presse Med. 1996, 25: 1546-1547. El Harrar: Anaphylactic shock caused by application of fluorescein on the ocular conjunctiva. Presse Med. 1996, 25: 1546-1547.
6.
go back to reference Moneret-Vautrin DA: Apropos of anaphylactic shock caused by application of fluorescein on the ocular conjunctiva. Presse Med. 1997, 26: 420-PubMed Moneret-Vautrin DA: Apropos of anaphylactic shock caused by application of fluorescein on the ocular conjunctiva. Presse Med. 1997, 26: 420-PubMed
7.
go back to reference Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC: Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization. J Allergy Clin Immunol. 2004, 113: 832-836. 10.1016/j.jaci.2003.12.591.CrossRefPubMed Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC: Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization. J Allergy Clin Immunol. 2004, 113: 832-836. 10.1016/j.jaci.2003.12.591.CrossRefPubMed
8.
go back to reference Tanus T, Mines D, Atkins PC: Serum tryptase in idiopathic anaphylaxis: a case report and review of the literature. Ann Emerg Med. 1994, 24: 104-107. 10.1016/S0196-0644(94)70169-5.CrossRefPubMed Tanus T, Mines D, Atkins PC: Serum tryptase in idiopathic anaphylaxis: a case report and review of the literature. Ann Emerg Med. 1994, 24: 104-107. 10.1016/S0196-0644(94)70169-5.CrossRefPubMed
9.
go back to reference Kahn M, Barney NP, Briggs RM, Bloch KJ, Allansmith MR: Penetrating the conjunctival barrier. Invest Ophthalmol Vis Sci. 1990, 31: 258-261.PubMed Kahn M, Barney NP, Briggs RM, Bloch KJ, Allansmith MR: Penetrating the conjunctival barrier. Invest Ophthalmol Vis Sci. 1990, 31: 258-261.PubMed
10.
go back to reference Pumphrey R: Anaphylaxis: can we tell who is at risk of a fatal reaction?. Curr Opin Allergy Clin Imunol. 2004, 4: 285-290. 10.1097/01.all.0000136762.89313.0b.CrossRef Pumphrey R: Anaphylaxis: can we tell who is at risk of a fatal reaction?. Curr Opin Allergy Clin Imunol. 2004, 4: 285-290. 10.1097/01.all.0000136762.89313.0b.CrossRef
Metadata
Title
Anaphylactic response to topical fluorescein 2% eye drops: a case report
Authors
Humma Shahid
John F Salmon
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2010
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-4-27

Other articles of this Issue 1/2010

Journal of Medical Case Reports 1/2010 Go to the issue